Investigative Ophthalmology & Visual Science · 2008 · 39 citations · 13 references
MedicineOphthalmologySurgeryOcular Drug DeliveryOcular PharmacologyOphthalmic SurgeryRabbit OphthalmologyRetinal DetachmentTransscleral Drug DeliveryAqueous Humor DiagnosticsControl Group DesignDrug Delivery To The VitreousNeedle-based Ocular AdministrationRabbit ModelsRabbit VisionRetinal Detachment Assessment
PURPOSE: To evaluate subretinal detection of bevacizumab 2 hours after intravitreous injection of 1.25 mg in rabbit eyes. METHODS: Anterior chamber paracentesis using a 30-gauge needle was performed in nine female Dutch-belted rabbits by removal of 0.05 mL of aqueous humor. Transscleral retinal detachment was performed with a modified 25-gauge infusion cannula connected to a bottle of physiologic saline solution (PSS). The animals were divided into experimental group 1, with intravitreous injection of 0.05 mL of (1.25 mg) with a 30-gauge needle (n = 6) and the control group 2, with intravitreous injection of 0.05 mL of PSS with a 30-gauge needle (n = 3). Two hours after the intravitreous bevacizumab or PSS injection, subretinal fluid was aspirated and immunoassayed to measure the level of bevacizumab. The rabbits were killed by intravenous pentobarbital injection. The eyes were enucleated and fixed in 10% formaldehyde. The pars plana site at which the transscleral cannula was introduced was analyzed by light microscopy, to exclude iatrogenic retinal tears. Eyes with accidental retinal tears were excluded. RESULTS: Subretinal bevacizumab molecules were detected in the six eyes that received an intravitreous bevacizumab injection. No subretinal bevacizumab was detected in the control eyes. Light microscopy showed no evidence of retinal tears or holes in any rabbits used for the bevacizumab detection and control group. CONCLUSIONS: Bevacizumab molecules were detected in the subretinal space after intravitreous injection of 1.25 mg of bevacizumab, possibly as the result of diffusion through the retina in a rabbit model.
13
Pegaptanib for Neovascular Age-Related Macular Degeneration
Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations
Systemic Therapy for Colorectal Cancer
Anna M. Varghese · DeckerMed CGSO Case-Based Reviews · 2019 · 883 citations
Medicine, Oncology, Pharmacology +17